Pharmacy Report Archives - Page 94 of 153 - Becker's Hospital Review

Top PBMs by market share | CVS inks deal with clinical trial platform | Amazon Care expands nationwide | COVID treatments earned 4 drugmakers $14B in '21 | CDC to trim booster timeline for immunocompromised | 5 recent drug approvals

February 8, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. CVS inks deal to bring clinical trials to pharmacies Full story 2. COVID-19 treatments earned 4 drugmakers $14B in 2021 Full story 3. PBMs ranked by market share: CVS Caremark is…

Pharmacist salary by state | 810 drugs saw price hikes in Jan. | Walgreens, CVS lift rapid test purchase limits | States move to block CMS vaccine rule | Uninsured struggle to access COVID antivirals

February 7, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 810 drugs saw price hikes in 1 month: 5 notes Full story 2. Pharmacist salary by state: Alaska is No. 1 at $147,040 Full story 3. Walgreens, CVS lift rapid test…

6 pharmacies with largest supply of Merck's antiviral | Vaccinations down in 47 states | Why do some people lose smell, taste from COVID? 1 explanation | 31% of parents will get kids under 5 vaccinated ASAP

February 3, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 6 pharmacies with largest supply of Merck's COVID-19 antiviral Full story 2. Why do some people lose smell, taste from COVID-19? 1 explanation Full story 3. COVID-19 vaccination rates up in…

2 surprising contract terms in Pfizer's antiviral deal with US | Magellan's PBM to deliver meds via drone | An unexpected omicron symptom | Vt. leads pack in boosters | Pfizer asks FDA to clear vaccine for kids under 5

February 2, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Magellan Health to deliver prescriptions via drones Full story 2. 2 surprising contract terms in Pfizer's antiviral deal with US Full story 3. Gilead saw $5.6B in remdesivir sales last…

What's next for Mark Cuban's drug firm? | Meijer pharmacies to offer free at-home PCR tests | Pfizer shot may be ready for kids under 5 by late Feb. | CMS cuts payments to 764 hospitals | 6 recent drug recalls

February 1, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. What's next for Mark Cuban's drug company? Full story 2. Pfizer's vaccine for kids under 5 could be available in a month; 2 more vaccine updates Full story 3. Meijer…

Drug prices up 6.6% in 2022 | San Francisco permits 3rd doses for J&J recipients | Mass. system ousts CEO | Merck antiviral effective against omicron | Watch for RX errors amid pharmacy staff shortages, physician warns

January 31, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Drugmakers raise prices 6.6% this year Full story 2. Incorrect prescriptions prompts physician warning: Check medication before leaving pharmacy Full story 3. San Francisco allows 3rd COVID-19 shot for J&J…

10 top drug safety concerns | Merck vs. Pfizer's antiviral: 11 notes | Pharmacist gets 5-year sentence in $180M fraud scheme | 'An invisible HHS secretary' | CDC reminds pharmacies of vaccine guidelines for immunocompromised

January 27, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 10 top medication safety concerns from 2021 Full story 2. CDC reminds pharmacies of vaccine guidelines for immunocompromised Full story 3. Pharmacist gets 5-year sentence in $180M healthcare fraud scheme Full…

Why 2 pharmacists left their roles | FDA blasts Eli Lilly for 'misleading' ads | Booster rates, by state | Insurers pay up to 74% of costs for ivermectin | 'Endemic' can be dangerous | Vaccine, treatment efficacy against omicron: 6 notes

January 26, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Why 2 pharmacists left their roles Full story 2. FDA blasts Eli Lilly for 'misleading' Instagram ads Full story 3. States ranked by booster rates: Jan. 26 Full story 4. Cedars-Sinai consistently hires…

27 drugs Mark Cuban's co. offers for at least $100 less | Some pharmacies deny 4th shots to immunocompromised | FDA limits use of 2 antibody drugs | Omicron deaths mirror delta wave | Immune protection lasts 4 mos. after Pfizer booster

January 25, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 27 medications with the biggest price cuts on Mark Cuban's online pharmacy Full story 2. FDA limits use of two COVID-19 antibody treatments due to omicron Full story 3. US pharmacies…

Remdesivir OK for outpatient use: FDA | CDC shifts focus from 'fully vaccinated' to 'up to date' | 12 drugmakers restricting 340B discounts | Patients can access Rx savings through their TVs | 6 COVID forecasts for the week

January 24, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA authorizes remdesivir as outpatient COVID-19 treatment Full story 2. Patients can now access prescription savings through their TV Full story 3. Omicron will peak in most states by mid-February…